CervoMed (CRVO)
2.75
-0.12 (4.18%)
Upcoming Events
Latest Headlines
CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 10, 2026 7:30 AM - StreetInsider
CervoMed (CRVO) PT Lowered to $18 at Canaccord
August 10, 2026 7:00 AM - StreetInsider
Form S-8 CervoMed Inc.
August 7, 2026 4:55 PM - SEC Filing
Form 10-Q CervoMed Inc. For: Jun 30
August 7, 2026 4:27 PM - SEC Filing
CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference
August 5, 2026 7:30 AM - StreetInsider
Form 8-K CervoMed Inc. For: Aug 04
August 4, 2026 7:52 AM - SEC Filing
CervoMed's neflamapimod receives UK innovation passport for DLB
August 4, 2026 6:00 AM - StreetInsider
CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)
August 4, 2026 5:15 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO)
July 15, 2026 7:40 AM - StreetInsider
Form 8-K CervoMed Inc. For: Jul 14
July 14, 2026 4:21 PM - SEC Filing
CervoMed presents neflamapimod DLB trial data at AAIC 2026
July 14, 2026 7:32 AM - StreetInsider
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
July 14, 2026 7:30 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO)
July 13, 2026 6:40 AM - StreetInsider
Form EFFECT CervoMed Inc.
July 13, 2026 6:02 AM - SEC Filing
Form 424B3 CervoMed Inc.
July 10, 2026 5:27 PM - SEC Filing
Form 8-K CervoMed Inc. For: Jul 09
July 9, 2026 4:10 PM - SEC Filing
CervoMed completes enrollment in Phase 2 nfvPPA dementia trial
July 9, 2026 7:30 AM - StreetInsider
CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia
July 9, 2026 7:30 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO)
July 9, 2026 6:53 AM - StreetInsider
Form SCHEDULE 13G/A CervoMed Inc. Filed by: MORGAN STANLEY
July 8, 2026 5:43 PM - SEC Filing
CervoMed (CRVO) for 10.08M share offering by selling stockholders
July 6, 2026 5:05 PM - StreetInsider
Form S-3 CervoMed Inc.
July 6, 2026 5:01 PM - SEC Filing
CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026
July 6, 2026 7:30 AM - Globe NewsWire
CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026
July 6, 2026 7:30 AM - StreetInsider
Form SCHEDULE 13G CervoMed Inc. Filed by: CVI Investments, Inc.
June 26, 2026 10:00 AM - SEC Filing
Form 8-K CervoMed Inc. For: Jun 22
June 22, 2026 4:13 PM - SEC Filing
CervoMed closes $10M stock offering at $4.00 per share
June 22, 2026 4:05 PM - StreetInsider
CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
June 22, 2026 4:05 PM - StreetInsider
Form 424B5 CervoMed Inc.
June 22, 2026 6:16 AM - SEC Filing
Form 8-K CervoMed Inc. For: Jun 18
June 22, 2026 6:02 AM - SEC Filing
CervoMed raises $10 million in registered direct stock offering
June 18, 2026 12:35 PM - StreetInsider
CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
June 18, 2026 12:35 PM - Globe NewsWire
Form 8-K CervoMed Inc. For: Jun 16
June 18, 2026 7:22 AM - SEC Filing
CervoMed receives U.S. patent for neflamapimod in pure DLB to 2042
June 18, 2026 7:00 AM - StreetInsider
CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042
June 18, 2026 7:00 AM - StreetInsider
Wall Street Chases the Next Big Breakout
June 16, 2026 3:23 PM - StreetInsider
Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum
June 16, 2026 10:19 AM - StreetInsider
Form SCHEDULE 13D/A CervoMed Inc. Filed by: BOGER JOSHUA S
June 15, 2026 5:38 PM - SEC Filing
Form 4 CervoMed Inc. For: Jun 11 Filed by: BOGER JOSHUA S
June 15, 2026 5:37 PM - SEC Filing
Form 8-K CervoMed Inc. For: Jun 15
June 15, 2026 5:00 PM - SEC Filing
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
June 12, 2026 7:30 AM - StreetInsider
Form 4 CervoMed Inc. For: Jun 08 Filed by: ZAVRL FRANK
June 10, 2026 7:45 PM - SEC Filing
Form 4 CervoMed Inc. For: Jun 08 Filed by: Sabbagh Marwan
June 10, 2026 7:45 PM - SEC Filing
Form 4 CervoMed Inc. For: Jun 08 Filed by: Quigley David
June 10, 2026 7:44 PM - SEC Filing
Form 4 CervoMed Inc. For: Jun 08 Filed by: Poulton Jeffrey V.
June 10, 2026 7:44 PM - SEC Filing
Form 4 CervoMed Inc. For: Jun 08 Filed by: Hollingsworth Jane H
June 10, 2026 7:43 PM - SEC Filing
Form 4 CervoMed Inc. For: Jun 08 Filed by: Gregoire Sylvie
June 10, 2026 7:43 PM - SEC Filing
Form 4 CervoMed Inc. For: Jun 08 Filed by: BOGER JOSHUA S
June 10, 2026 7:43 PM - SEC Filing
Form 4 CervoMed Inc. For: Jun 08 Filed by: ALAM JOHN J
June 10, 2026 7:42 PM - SEC Filing
CervoMed (CRVO) PT Lowered to $15 at Brookline Capital Markets
June 10, 2026 5:02 PM - StreetInsider
Form 8-K CervoMed Inc. For: Jun 09
June 10, 2026 7:41 AM - SEC Filing
CervoMed raises $10.5 million, seeks partnership for dementia drug
June 10, 2026 7:30 AM - StreetInsider
CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies
June 10, 2026 7:30 AM - StreetInsider
Form 8-K CervoMed Inc. For: Jun 08
June 9, 2026 6:06 AM - SEC Filing
Form 8-K CervoMed Inc. For: May 18
May 18, 2026 4:58 PM - SEC Filing
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 18, 2026 7:30 AM - Globe NewsWire
Form 10-Q CervoMed Inc. For: Mar 31
May 15, 2026 9:12 AM - SEC Filing
Full Article List
